PGE1-induced NO reduces apoptosis by D-galactosamine through attenuation of NF-κB and NOS-2 expression in rat hepatocytes

Hepatology

Volumn 40, Issue 6, 2004, Pages 1295-1303

  Siendones, Emilio ^a   Fouad, Dalia ^a   Díaz Guerra, Maria José M ^b   De La Mata, Manuel ^a   Boscá, Lisardo ^b   Muntané, Jordi ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; GALACTOSAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN E1; CYTOKINE; FIBRINOLYTIC AGENT; I KAPPA B; LIPOPOLYSACCHARIDE; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CELL ISOLATION; CONTROLLED STUDY; CYTOTOXICITY; DNA TRANSFECTION; ENZYME ACTIVITY; LIVER CELL; LIVER PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; ANIMAL; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FEEDBACK SYSTEM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ALPROSTADIL; ANIMALS; APOPTOSIS; CELLS, CULTURED; CYTOKINES; FEEDBACK, BIOCHEMICAL; FIBRINOLYTIC AGENTS; GALACTOSAMINE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATOCYTES; I-KAPPA B PROTEINS; LIPOPOLYSACCHARIDES; MALE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROMOTER REGIONS (GENETICS); RATS; RATS, WISTAR;

EID: 10644242646     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20448     Document Type: Article

References (49)

1. Bergstrom S, Carlson LA, Weeks JR. The prostaglandins: a family of biologically active lipids. Pharmacol Rev 1968;20:1-48.
2. Quiroga J, Prieto J. Liver cytoprotection by prostaglandins. Pharmacol Ther 1993;58:67-91.
3. Sinclair SB, Greig PD, Blendis LM, Abecassis M, Roberts EA, Phillips MJ, et al. Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. J Clin Invest 1989;84:1063-1069.
4. Stachura J, Tarnawski A, Ikey KJ, March T, Bogdal J, Szczudrawa J, et al. Prostaglandin protection of carbon tetrachloride-induced liver cell necrosis in the rat. Gastroenterology 1981;81:211-217.
5. Miura Y, Fukui N. Prostaglandins as possible triggers for liver regeneration after partial hepatectomy. Cell Mol Biol 1979;25:179-184.
6. 1 results in increased graft and patient survival. Transplant Proc 1989;21:2385-2388.
7. 2 delays collagen formation in nutritional injury in rat liver. HEPATOLOGY 1988;8:61-64.
8. 1 protection against acute liver injury. Gut 2000;47:553-562.
9. Imai T, Hirata Y, Kanno K, Marumo, F. Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells. J Clin Invest 1994;93:543-549.
10. Oddis CV, Simmons RL, Hauler BG, Finkel MS. cAMP enhances inducible nitric oxide synthase mRNA stability in cardiac myocytes. Am J Physiol 1995;269:H2044-H2050.
11. Kunz D, Muhl H, Walker G, Pfeilschifter J. Two distinct signaling pathways trigger the expression of inducible nitric oxide synthase in rat renal mesangial cells. Proc Natl Acad Sci U S A 1994;91:5387-5391.
12. Mullet D, Fertel RH, Kniss D, Cox GW. An increase in intracellular cAMP modulates nitric oxide production in IFN-gamma-treated macrophages. J Immunol 1997;158:897-904.
13. Harbrecht BG, Taylor BS, Xu Z, Ramalakshmi S, Ganster RW, Geller DA. cAMP inhibits inducible nitric oxide synthase expression and NF-kappaB-binding activity in culture rat hepatocytes. J Surg Res 2001;99:258-264.
14. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 1994;10:405-455.
15. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 1996;274:787-789.
16. Beg AA, Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996;274:782-784.
17. De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R, Jones J, et al. Induction of gadd45beta by NF-kappaB down regulates pro-apoptotic JNK signaling. Nature 2001;414:308-313.
18. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and C-IAP2 to suppress caspase-8 activation. Science 1998;281:1680-1683.
19. Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH, Ballard DW. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis C-IAP2 is under NF-kappaB control. Proc Natl Acad Sci U S A 1997;94:10057-10062.
20. Lee HH, Dadgostar H, Cheng Q, Shu J, Cheng G. NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc Natl Acad Sci U S A 1999;96:9136-9141.
21. Griffith OW, Stuehr DJ. Nitric oxide synthases: properties and catalytic mechanism. Annu Rev Physiol 1995;57:707-736.
22. Geller DA, Nussler AK, Di Silvio M, Lowenstein CJ, Shapiro RA, Wang SC, et al. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Nad Acad Sci U S A 1993;90:522-526.
23. Taylor BS, De Vera ME, Ganster RW, Wang Q, Shapiro RA, Morris SM, et al. Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J Biol Chem 1998;273:15148-15156.
24. Diaz-Guerra MJM, Velasco M, Martin-Sanz P, Bosca L. Evidence for common mechanism in the transcriptional control of type II nitric oxide synthase in isolated hepatocytes. J Biol Chem 1996;271:30114-30120.
25. Clemens MG. Nitric oxide in liver injury. HEPATOLOGY 1999;30:1-5.
26. Kim YM, Chung HT, Simmons RL, Billiar TR. Cellular non-heme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition. J Biol Chem 2000;275:10954-10961.
27. Kim YM, Talanian RV, Billiar TR. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 1997;272:31138-31148.
28. Gumpricht E, Dahl R, Yerushalmi B, Devereaux MW, Sokol RJ. Nitric oxide ameliorates hydrophobic bile acid-induced apoptosis in isolated rat hepatocytes by non-mitochondrial pathways. J Biol Chem 2002;277:25823-25830.
29. Hatano E, Bennet BL, Manning AM, Qian T, Lemasters JJ, Brenner DA. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis. Gastroenterology 2001;120:1251-1262.
30. Abou-Elella AM, Siendones E, Padillo J, Montero JL, De la Mata M, Relat JM. Tumour necrosis factor-alpha and nitric oxide mediate apoptosis by D-galactosamine in a primary culture of rat hepatocytes: exacerbation of cell death by cocultured Kupffer cells. Can J Gastroenterol 2002;16:791-799.
31. 1 in cultured hepatocytes. Nitric Oxide 2003;8:133-143.
32. Seglen PO. Preparation of isolated rat liver cells. Method Cell Biol 1976;13:29-83.
33. Schreiber E, Matthias P, Muller MM, Schaffner W. Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells. Nucleic Acids Res 1989;17:6419.
34. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-408.
35. 1 protection against D-galactosamine-induced cell death in cultured rat hepatocytes. Liver Int 2004;24:227-236.
36. Quintero A, Pedraza CA, Siendones E, ElSaid AMK, Colell A, García-Ruiz C, et al. PGE1 protection against apoptosis induced by D-galactosamine is not related to the modulation of intracellular free radical production in primary culture of rat hepatocytes. Free Radic Res 2002;36:345-355.
37. Harbrecht BG, Kim YM, Wirant EM, Shaphiro RA, Billiar TR. PGE2 and LTB4 inhibit cytokine-stimulated nitric oxide synthase type 2 expression in isolated rat hepatocytes. Prostaglandins 1996;52:103-116.
38. Galea E, Feinstein DL Regulation of the expression of the inflammatory nitric oxide synthase (NOS2) by cyclic AMP. FASEB J 1999;13:2125-2137.
39. Gavrilyuk V, Horvath P, Weinberg G, Feinstein GL. A 27-bp region of the inducible nitric oxide synthase promoter regulates expression in glial cells. J Neurochem 2001;78:129-140.
40. Keppler D, Lesch R, Reutter W, Decker K. Experimental hepatitis induced by D-galactosamine. Exp Mol Pathol 1968;9:279-290.
41. Muntané J, Montero JL, Marchai T, Pérez-Seoane C, Lozano JM, Fraga E, et al. Effect of PGE1 on TNF-alpha status and hepatic D-galactosamine-induced apoptosis in rats. J Gastroenterol Hepatol 1998;13:197-207.
42. Muntané J, Montero JL, Lozano JM, Miranda-Vizuete A, de la Mata M, Mifio G. TNF-alpha but not II-1alpha are correlated with PGE1-dependent protection against acute D-galactosamine-induced liver injury. Can J Gastroenterol 2000;14:175-180.
43. Tsutsui S, Hirasawa K, Takeda M, Itagaki S, Kawamura S, Maeda K, et al. Apoptosis of murine hepatocytes induced by high doses of galactosamine. J Vet Med Sci 1997;59:785-790.
44. Tran-Thi TA, Phillips J, Falk H, Decker K. Toxicity of D-galactosamine for rat hepatocytes in monolayer culture. Exp Mol Pathol 1985;42:89-116.
45. Taylor BS, Kim YM, Wang Q, Shapiro RA, Billiar TR, Geller DA. Nitric oxide down-regulates hepatocyte inducible nitric oxide synthase gene expression. Arch Surg 1997;132:1177-1183.
46. Griffon B, Cillard J, Chevanne M, Morel I, Cillard P, Sergent O. Macrophage-induced inhibition of nitric oxide production in primary rat hepatocyte cultures via prostaglandin E2 release. HEPATOLOGY 1998;28:1300-1308.
47. Mojena M, Hortelano S, Castrillo A, Díaz-Guerra MJM, García-Barchino MJ, Sáez GT, et al. Protection by nitric oxide against liver inflammatory injury in animals carrying a nitric oxide synthase-2 transgene. FASEB J 2001;15:583-585.
48. Choi BM, Pae HO, Chung HT. Nitric oxide priming protects nitric oxide-mediate apoptosis via heme oxygenase-1 induction. Free Radical Biol Med 2003;34:1136-1145.
49. Leifeld L, Fielenbach M, Dumoulin FL, Speidel N, Sauerbruch T, Spengler U. Inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) expression in fulminant hepatic failure. J Hepatol 2002;37:613-619.